CRISPR Therapeutics AG - CRSP
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | ORBIS INVESTMENT MANAGEMENT LTD | 5.6% | 5,433,344 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Allan Gray Australia Pty Ltd | 0.0% | 15,817 | View |
| Jul 27, 2026 | SCHEDULE 13G/A | BlackRock, Inc. | 8.3% | 7,987,262 | View |
| May 15, 2026 | SCHEDULE 13G/A | ORBIS INVESTMENT MANAGEMENT LTD | 6.3% | 6,090,194 | View |
| May 15, 2026 | SCHEDULE 13G/A | Allan Gray Australia Pty Ltd | 0.0% | 15,817 | View |
| May 14, 2026 | SCHEDULE 13G | Capital World Investors | 5.1% | 4,929,428 | View |
| Apr 30, 2026 | SCHEDULE 13G/A | ARK Investment Management LLC | 11.79% | 11,313,623 | View |
| Apr 30, 2026 | SCHEDULE 13G/A | Catherine D. Wood | 11.79% | 11,313,623 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.